Suppr超能文献

肠道微生物组的扰动与恢复。

: Perturbation and restoration of gut microbiome.

机构信息

Amity Institute of Biotechnology, Amity University, Noida, India.

出版信息

J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00078-7.

Abstract

Alternate remedies with natural products provides unlimited opportunities for new drug development. These can be either as pure compounds or as standardized set of compounds. The phytochemicals and secondary metabolites are in great demand for screening bioactive compounds and plays an important role towards drug development. Natural products have many advantages over to synthetic chemical drugs. (H. pylori) a Gram-negative bacteria has been classified as Class I carcinogen by World Health Organization in 1994. Current treatment regimens for is 'triple therapy' administrated for two weeks which includes a combination of two antibiotics like Amoxicillin and Clarithromycin and a proton pump inhibitor (PPI) like Lansoprazole, and for 'quadruple therapy' in addition to antibiotics and a PPI, Bismuth is used. Antibiotic resistance can be named as the main factor for failure of treatment of infection. The need of the hour is to develop a herbal remedy that could combat the growth of . Probiotics can also be used as 'feasible' tool for infection management. Present review is an attempt to briefly discuss about the pathogenicity, genetic predisposition, perturbation of gut microbiota due to antibiotic treatment and restoration of healthy gut microbiota with phytochemicals and probiotics.

摘要

替代疗法与天然产物为新药开发提供了无限的机会。这些可以是纯化合物,也可以是标准化的化合物组合。植物化学物质和次生代谢物是筛选生物活性化合物的热门选择,对药物开发起着重要作用。天然产物相对于合成化学药物有许多优势。(幽门螺杆菌)于 1994 年被世界卫生组织列为 I 类致癌物。目前的治疗方案是“三联疗法”,持续两周,包括两种抗生素(如阿莫西林和克拉霉素)和一种质子泵抑制剂(PPI)(如兰索拉唑),而“四联疗法”除了抗生素和 PPI 之外,还使用铋剂。抗生素耐药性是导致治疗失败的主要因素。目前的当务之急是开发一种草药疗法来对抗的生长。益生菌也可以作为治疗感染的“可行”工具。本综述试图简要讨论的致病性、遗传易感性、抗生素治疗引起的肠道微生物群失调以及植物化学物质和益生菌对健康肠道微生物群的恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb1/7481552/57582cece4bc/12038_2020_78_Fig1_HTML.jpg

相似文献

1
: Perturbation and restoration of gut microbiome.
J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00078-7.
2
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Helicobacter. 2016 Jun;21(3):165-74. doi: 10.1111/hel.12270. Epub 2015 Sep 23.
9
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance.
Front Cell Infect Microbiol. 2017 May 5;7:168. doi: 10.3389/fcimb.2017.00168. eCollection 2017.
10
Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
Helicobacter. 2020 Oct;25(5):e12721. doi: 10.1111/hel.12721. Epub 2020 Jul 12.

引用本文的文献

1
Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective.
Gut Pathog. 2025 May 23;17(1):35. doi: 10.1186/s13099-025-00704-5.
2
Effect of Helicobacter pylori on sleeve gastrectomy and gastric microbiome differences in patients with obesity and diabetes.
Int J Obes (Lond). 2024 Nov;48(11):1664-1672. doi: 10.1038/s41366-024-01611-6. Epub 2024 Aug 24.
3
Changes in the tissue elements of the gastric mucosa interacting with different strains of , taking into consideration the patient's genotype.
Biosci Microbiota Food Health. 2024;43(3):213-221. doi: 10.12938/bmfh.2023-070. Epub 2024 Mar 19.
4
Current Knowledge about Gastric Microbiota with Special Emphasis on Related Gastric Conditions.
Curr Issues Mol Biol. 2024 May 20;46(5):4991-5009. doi: 10.3390/cimb46050299.
5
Association between dietary zinc intake and seropositivity in US adults: National Health and Nutrition Examination Survey.
Front Nutr. 2023 Sep 21;10:1243908. doi: 10.3389/fnut.2023.1243908. eCollection 2023.
6
A review on the research progress on non-pharmacological therapy of .
Front Microbiol. 2023 Mar 17;14:1134254. doi: 10.3389/fmicb.2023.1134254. eCollection 2023.
7
Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges.
Antibiotics (Basel). 2023 Jan 17;12(2):191. doi: 10.3390/antibiotics12020191.
8
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications.
Front Pharmacol. 2022 Jun 27;13:917184. doi: 10.3389/fphar.2022.917184. eCollection 2022.
9
Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.
Braz J Microbiol. 2022 Mar;53(1):33-50. doi: 10.1007/s42770-021-00675-0. Epub 2022 Jan 6.

本文引用的文献

1
The effect of supplementation in infection: a placebo-controlled, single-blind study.
BMC Nutr. 2018 Dec 7;4:48. doi: 10.1186/s40795-018-0257-4. eCollection 2018.
2
Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Fungal Genet Biol. 2020 Apr;137:103333. doi: 10.1016/j.fgb.2020.103333. Epub 2020 Jan 7.
3
Role of Oral Microbiota in Cancer Development.
Microorganisms. 2019 Jan 13;7(1):20. doi: 10.3390/microorganisms7010020.
4
Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?
Appl Microbiol Biotechnol. 2019 Feb;103(4):1573-1588. doi: 10.1007/s00253-018-09580-3. Epub 2019 Jan 4.
5
Helicobacter pylori, transmission routes and recurrence of infection: state of the art.
Acta Biomed. 2018 Dec 17;89(8-S):72-76. doi: 10.23750/abm.v89i8-S.7947.
6
Helicobacter pylori Infection: New Facts in Clinical Management.
Curr Treat Options Gastroenterol. 2018 Dec;16(4):605-615. doi: 10.1007/s11938-018-0209-8.
7
What Roles Do Probiotics Play in the Eradication of ? Current Knowledge and Ongoing Research.
Gastroenterol Res Pract. 2018 Oct 16;2018:9379480. doi: 10.1155/2018/9379480. eCollection 2018.
8
Considering gut microbiota disturbance in the management of Helicobacter pylori infection.
Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):899-906. doi: 10.1080/17474124.2018.1503946. Epub 2018 Aug 7.
9
Draft Genome Sequences of 42 Isolates from Rural Regions of South India.
Genome Announc. 2018 Feb 1;6(5):e01486-17. doi: 10.1128/genomeA.01486-17.
10
Probiotic monotherapy and eradication: A systematic review with pooled-data analysis.
World J Gastroenterol. 2018 Jan 7;24(1):139-149. doi: 10.3748/wjg.v24.i1.139.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验